A meta-analysis of the proportion of antimicrobial resistant human Salmonella isolates in Ethiopia

Table 5 MDR features of S . Concord

Author	MDR profiles	No. (%)
[13]^a	Amp Chl Cro Gen Sxt	41(48.8)
	Amp Chl Cro Gen Sxt Tet	29(34.5)
	Amp Chl Cro Gen Nal Sxt Tet	5(6.0)
[14]^b	Amp Azt Chl (Cep Cfp Cfr Cft Cfz Cpo Cro Ctz ) Str SulTmp	34(97.1)
	Amp Azt Chl (Cep Cfp Cfr Cft Cfz Cpo Ctz ) Str SulTmp	1(2.9)
[15]^c	Amp Chl Cro Gen Str Sul Sxt Tmp	3(11.5)
	Amp Chl Cro Gen Sul Str Sxt Tet Tmp	19(73.1)
	Amp Chl Cro Gen Nal Str Sul Sxt Tet Tmp	4(15.4)
[41]^d	Amp Chl Cfo Cro Gen Str Sul Tet Tmp	8 (100)

Amp = ampicillin; Azt = aztreonam; Cep = cephalothin; Cfo = cefotaxime; Cfp = cefepime; Cfr = cefuroxime; Cft = ceftiofur; Cfz = cefazolin; Cpo = cefpodoxime; Cro = ceftriaxone; Ctz = ceftazidime; Chl = chloramphenicol; Gen = gentamicin; Nal = nalidixic acid; Sul = sulfamethoxazole; Str = streptomycin; Sxt = co-trimoxazole; Tet = tetracycline; Tmp = trimethoprim.
^aEach profile was recorded in more than 5% of the MDR isolates. One isolate was resistant to ofloxacin.
^bResistance to gentamicin (97%), tetracycline (69%) and intermediate resistance to ciprofloxacin (14%) were recorded.
^cSeven isolates showed intermediate resistance to ciprofloxacin.
^dResistance to florfenicol (6/8), colistin (1/8) and intermediate resistance to ciprofloxacin (6/8) were recorded.

ISSN: 2050-6511